Avania Revenue and Competitors

Bilthoven, Netherlands

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Avania's estimated annual revenue is currently $35M per year.(i)
  • Avania's estimated revenue per employee is $110,759

Employee Data

  • Avania has 316 Employees.(i)
  • Avania grew their employee count by 9% last year.

Avania's People

NameTitleEmail/Phone
1
Founder and Global Head StrategyReveal Email/Phone
2
Executive Director Business Development (US)Reveal Email/Phone
3
Group CFOReveal Email/Phone
4
SVP OperationsReveal Email/Phone
5
SVP OperationsReveal Email/Phone
6
Head Corporate Development / M&AReveal Email/Phone
7
Director, Clinical OperationsReveal Email/Phone
8
Chief Commercial Officer (CCO)Reveal Email/Phone
9
Project Delivery DirectorReveal Email/Phone
10
Executive Director, Business Development (AUS)Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A2567%N/AN/A
#2
$35M3169%N/AN/A
Add Company

What Is Avania?

Avania brings knowledgeable experts together to form a unique CRO that advances the research of medical devices, novel technology, and combination products across a wide range of therapeutic specialties. Our motivated team takes you from feasibility all the way through post-market trials. Our experts in data management and analytics, clinical trial design & execution, strategic consulting, regulatory, reimbursement, and more will provide you with customized, scalable solutions that optimize efficiencies and streamline the advancement of your medical technology. Your product is important, and your company deserves the team that has what it takes. It takes knowledge. It takes passion. It takes commitment. It takes Avania.

keywords:N/A

N/A

Total Funding

316

Number of Employees

$35M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Avania News

2021-02-26 - Avania in Position for Next Stage of Growth

BILTHOVEN, Netherlands--(BUSINESS WIRE)--Feb 26, 2021-- Avania, a leading global full-service contract research organization (CRO) focused on medical technology (MedTech) development, today announced that it has successfully refinanced its existing banking facilities with Crescent Capital Group ...